Home/Filings/4/0001062993-24-004239
4//SEC Filing

Smeykal Megan 4

Accession 0001062993-24-004239

CIK 0001561921other

Filed

Feb 22, 7:00 PM ET

Accepted

Feb 23, 4:13 PM ET

Size

6.5 KB

Accession

0001062993-24-004239

Insider Transaction Report

Form 4
Period: 2024-02-21
Smeykal Megan
Chief Accounting OfficerOther
Transactions
  • Tax Payment

    Common Stock

    2024-02-21$7.00/sh795$5,56520,658 total
  • Award

    Common Stock

    2024-02-21+9,40030,058 total
Footnotes (3)
  • [F1]Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.
  • [F2]Includes 1,022 shares acquired under the Company's employee stock purchase plan on January 31, 2024.
  • [F3]These restricted stock units will vest in four equal annual installments beginning on February 21, 2025, subject to the Reporting Person's continuous service through the applicable vesting dates.

Issuer

TELA Bio, Inc.

CIK 0001561921

Entity typeother

Related Parties

1
  • filerCIK 0001899973

Filing Metadata

Form type
4
Filed
Feb 22, 7:00 PM ET
Accepted
Feb 23, 4:13 PM ET
Size
6.5 KB